BioSpace News Archive

Spinal Elements, a spine technology company, today announced the publication of positive clinical outcomes data with the Luna XD multi-expandable implant system.

Bio-Thera Solutions, Ltd. today announced that dosing has begun in a Phase III clinical study for BAT2506, a proposed biosimilar of Simponi® (golimumab).

Evoke Pharma, Inc. (NASDAQ: EVOK), today announced that its US patent No. 11,020,361 for Gimoti® (metoclopramide) nasal spray is now listed in the U.S. Food and Drug Administration (FDA) publication, “Approved Drug Products with Therapeutic Equivalence Evaluations”, commonly known as the “Orange Book”.

ALR Technologies SG Pte. Ltd., the diabetes management company, announces the establishment of the ALRT Animal Health Division, a new business division which will introduce the world’s FIRST and ONLY CGM for diabetic companion animals.

Cardiff Oncology announced today that the first patient has been dosed in its Phase 2 clinical trial of onvansertib in combination with nanoliposomal irinotecan metastatic pancreatic ductal adenocarcinoma (PDAC).

DarioHealth Corp., a pioneer in the global digital therapeutics market, announced the consummation of the previously announced acquisition of PsyInnovations, Inc. through the merger of PsyInnovations into DarioHealth’s wholly-owned subsidiary, WF Merger Sub, Inc., which changed its name to PsyInnovations, Inc.

EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has received CE Mark for its EndoArt®, after clinical trials demonstrated safety and efficacy for treating chronic corneal edema.

Dr. Jacob Haiavy has pioneered a technique for placing silicone gel-filled breast implants through transumbilical breast augmentation, a procedure previously believed to only allow for saline breast implant placement.

Collaboration with 23andMe enables robust sharing of de-identified genetic data with researchers worldwide through the Fox Insight Data Exploration Network (Fox DEN)

Bioclinica, an ERT company, announced the addition of eConsent as part of its Electronic Data Capture and Management suite of products.